Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

Benjamin K. Chen, MD, PhD, discussed the next steps after the results of his study in genetic tagging showed promise in ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

A mathematical modeling study coordinated by UMC Utrecht has shown that sustained HIV remission (without rebound) or HIV ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Mar. 19, 2025 — New study demonstrates how high-affinity B cells 'bank' their ... organ from donors who are also HIV positive as it is from donors who are not infected with the ...

During acute and early HIV infection, high levels of viremia generate a massive immunologic response, which in turn contributes to rapid CD4-cell depletion. Given this process, researchers have ...

Traditionally, viruses have been thought of as a burden that cause disease. Now, viruses are being harnessed to tackle ...

A University of Utah professor is being recognized as one of Time's most influential people for his work in creating ...

The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be ...

A University of Utah professor is being recognized as one of Time's most influential people for his work in creating lenacapavir, a long-lasting HIV prevention and treatment drug.